...
首页> 外文期刊>Nephrology Dialysis Transplantation >When should we commence dialysis? The story of a lingering problem and today's scene after the IDEAL study
【24h】

When should we commence dialysis? The story of a lingering problem and today's scene after the IDEAL study

机译:我们什么时候应该开始透析?一个棘手的问题的故事和IDEAL学习后的今天场景

获取原文
获取原文并翻译 | 示例

摘要

Over the last 15–20 years, there has been an increasing trend for dialysis to be commenced earlier in the development of chronic kidney disease (CKD). The drivers for initiation of dialysis at higher levels of renal function are complex but were primarily based on the assumption that by improving solute and water clearances with earlier dialysis, morbidity, mortality and quality of life would be improved. The Initiating Dialysis Early and Late (IDEAL) trial definitively demonstrated that elective earlier initiation of dialysis was not associated with improved clinical outcomes or quality of life. Indeed, no subset of patients was found to benefit from earlier dialysis. Observational data suggests that patients who commence dialysis with higher levels of renal function are more likely to have significant comorbidity that results in higher mortality rates compared to patients who remain clinically well and biochemically stable and are able to defer the initiation of dialysis till later in the course of CKD. However, patients who are able to defer dialysis should have appropriate access created so as to avoid the use of temporary catheters and to facilitate initiation using the preferred dialysis modality. Estimates of glomerular filtration rates in Stage 5 CKD have been poorly validated and should not be used as the key determinant influencing the commencement of dialysis. The results of the IDEAL trial have influenced guidelines internationally and provide clinicians, patients and health care providers with important information to drive clinical decision making and rational service planning.
机译:在过去的15至20年中,在慢性肾脏病(CKD)的发展过程中,越来越早开始进行透析的趋势不断增加。在较高的肾功能水平下开始透析的驱动因素很复杂,但主要基于这样的假设:通过在早期透析中改善溶质和水清除率,发病率,死亡率和生活质量将得到改善。早期和晚期透析(IDEAL)试验明确表明,选择性的早期透析开始与改善的临床结局或生活质量无关。确实,没有发现任何患者受益于早期透析。观察数据表明,与临床上保持良好状态和生化稳定并且能够将透析开始推迟到后期的患者相比,开始以较高肾功能水平进行透析的患者更有可能出现明显的合并症,从而导致更高的死亡率。 CKD病程。但是,能够推迟透析的患者应具有适当的进入通道,以避免使用临时导管,并有利于使用首选透析方式进行启动。 CKD第5阶段肾小球滤过率的估计值尚未得到有效验证,因此不应用作影响透析开始的关键因素。 IDEAL试验的结果已在国际上影响了指南,并为临床医生,患者和医疗保健提供者提供了重要信息,以推动临床决策和合理的服务计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号